Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience.

Antonio FarinaSilvia FalsoSara CornacchiniGregorio SpagniGabriele Monte Alice MariottiniLuca MassacesiAlessandro BarilaroAmelia EvoliValentina Damato

Published in: European journal of neurology (2022)

Our data support the safety and tolerability of mRNA COVID-19 vaccines, which should be strongly recommended in MG patients, who could be at higher risk of complications if exposed to SARS-CoV-2 infection.

Keyphrases

sars cov
myasthenia gravis
respiratory syndrome coronavirus
open label
coronavirus disease
double blind
electronic health record
risk factors
placebo controlled
randomized controlled trial
cross sectional
big data